MedPath
HSA Approval

Apo-Paroxetine 20mg Tablet

SIN13485P

Apo-Paroxetine 20mg Tablet

Apo-Paroxetine 20mg Tablet

July 10, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06AB05

paroxetine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc

Active Ingredients

Paroxetine Hydrochloride 22.2mg eqv to Paroxetine

20.0mg

Paroxetine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Apo-Paroxetine 20mg Tablet - HSA Approval | MedPath